| Lee, Seung-Hwan |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk |
|
|
| Active, not recruiting | 3 | 2749 | Europe, US, RoW | Orforglipron, LY3502970, Insulin Glargine | Eli Lilly and Company | Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease | 09/25 | 01/26 | | |
NCT06712615: Phase II Study of PG-102(MG12) Compared with Placebo in Obesity and Type 2 Diabetes |
|
|
| Recruiting | 2 | 144 | RoW | PG-102, Placebo | ProGen. Co., Ltd. | Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus | 03/25 | 06/25 | | |
| Active, not recruiting | 2 | 145 | Europe, Canada, Japan, US, RoW | GSK3858279, Placebo | GlaxoSmithKline | Pain | 10/24 | 01/25 | | |
NCT06155487: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects |
|
|
| Enrolling by invitation | 1 | 68 | RoW | AJH-2947 100 mg (SAD), Placebo, AJH-2947 200 mg (SAD), AJH-2947 300 mg (SAD), AJH-2947 400 mg (SAD), AJH-2947 600 mg (SAD), AJH-2947 800 mg (SAD), AJH-2947 200 mg (MAD), AJH-2947 400 mg (MAD), AJH-2947 600 mg (MAD) | JMackem Co., Ltd, Seoul National University Hospital | Neuropathic Pain, Diabetic Neuropathies, Post Herpetic Neuralgia | 04/25 | 09/25 | | |
NCT03611725: Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI |
|
|
| Completed | N/A | 352 | RoW | Distal radial artery, Radial artery | Wonju Severance Christian Hospital, Hanmi Pharmaceutical co., ltd. | Distal Radial Artery Approach, ST Elevation Myocardial Infarction | 03/23 | 12/23 | | |
| Recruiting | N/A | 5000 | RoW | | Yonsei University, Gangwon Cardiovascular Health Research Institute | Coronary Artery Disease | 12/30 | 12/31 | | |
| Yoo, Byung-Su |
| Recruiting | 4 | 100 | RoW | Carvedilol, carvedilol slow-release (SR), Placebo | Seoul National University Bundang Hospital, Samsung Medical Center, Wonju Severance Christian Hospital | Heart Failure With Preserved Ejection Fraction, Beta Blocker, Myocardial Strain | 08/24 | 12/24 | | |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
ACHIEVE-4, NCT05803421: A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk |
|
|
| Active, not recruiting | 3 | 2749 | Europe, US, RoW | Orforglipron, LY3502970, Insulin Glargine | Eli Lilly and Company | Type 2 Diabetes, Obesity, Overweight or Obesity, Overweight, Cardiovascular Diseases, Chronic Kidney Disease | 09/25 | 01/26 | | |
| Active, not recruiting | 3 | 15374 | Europe, Canada, Japan, US, RoW | Tirzepatide, LY3298176, Placebo | Eli Lilly and Company | Obesity, Overweight | 10/27 | 10/27 | | |
TRANS-HF, NCT04900584: Optimize Heart Failure Care During TRANSitional Period in Patients With Acute Heart Failure. |
|
|
| Active, not recruiting | N/A | 1009 | RoW | Checklist, Education, Telephone monitoring | Wonju Severance Christian Hospital, Korean Center for Disease Control and Prevention | Heart Failure With Reduced Ejection Fraction, Acute Heart Failure | 10/22 | 02/23 | | |
| Completed | N/A | 84 | RoW | Bluetooth-connected monitoring devices and a feedback system, Mobile application | Seoul National University Bundang Hospital, KT Corporation | Heart Failure | 01/23 | 01/23 | | |
POSTBIO-HF, NCT04437628: Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure |
|
|
| Recruiting | N/A | 1500 | RoW | | Wonju Severance Christian Hospital, Roche diagnostics Korea | Heart Failure | 12/24 | 12/25 | | |
| Yoo, Byung Moo |
PARADE-HF, NCT05329727: The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF |
|
|
| Recruiting | N/A | 1000000 | RoW | Angiotensin receptor neprilysin inhibitor (ARNI), ARNI, Renin-Angiotensin System Inhibitor (RAS inhibitor), RAS inhibitor | Wonju Severance Christian Hospital | Heart Failure, Mortality | 06/22 | 12/25 | | |
| Cho, Dong-Hyuk |
NCT05194592: Comparison of the Effects of Dapagliflozin and Gemigliptin on Ketone Metabolism and Cardiac Remodeling in Type 2 Diabetes |
|
|
| Recruiting | 4 | 122 | RoW | Dapagliflozin, Gemigliptin | Wonju Severance Christian Hospital | Type2 Diabetes, Remodeling, Ventricular | 12/24 | 06/25 | | |
PARADE-HF, NCT05329727: The Comparative Effectiveness Between ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF |
|
|
| Recruiting | N/A | 1000000 | RoW | Angiotensin receptor neprilysin inhibitor (ARNI), ARNI, Renin-Angiotensin System Inhibitor (RAS inhibitor), RAS inhibitor | Wonju Severance Christian Hospital | Heart Failure, Mortality | 06/22 | 12/25 | | |
POSTBIO-HF, NCT04437628: Prognostic Value Of Short-Term Follow-up Biomarkers After Discharge In hOspitalized Patients With Acute Heart Failure |
|
|
| Recruiting | N/A | 1500 | RoW | | Wonju Severance Christian Hospital, Roche diagnostics Korea | Heart Failure | 12/24 | 12/25 | | |
NCT06779695: Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study) |
|
|
| Active, not recruiting | N/A | 2000 | RoW | | Korea University Anam Hospital, Korea University Ansan Hospital, Mediplex Sejong Hospital, Chungnam National University Hospital, Chonnam National University Hospital, Kyung Hee University Hospital at Gangdong, Kyungpook National University Hospital, Korea University Guro Hospital, InjeUniversityIlsanPaikHospital, Wonkwang University Hospital, Keimyung University Dongsan Medical Center | Atrial Fibrillation (AF) | 09/28 | 12/31 | | |
NCT06076551: Sex Difference of Coronary Microvascular Dysfunction in Patients With Non-obstructive Coronary Artery Disease |
|
|
| Recruiting | N/A | 300 | RoW | Adenosine stress echocardiography | Korea University Anam Hospital | Microvascular Angina | 12/24 | 12/24 | | |
